MX2023006038A - Vacunas contra el virus del papiloma humano y usos de estas para enfermedades asociadas a hpv. - Google Patents
Vacunas contra el virus del papiloma humano y usos de estas para enfermedades asociadas a hpv.Info
- Publication number
- MX2023006038A MX2023006038A MX2023006038A MX2023006038A MX2023006038A MX 2023006038 A MX2023006038 A MX 2023006038A MX 2023006038 A MX2023006038 A MX 2023006038A MX 2023006038 A MX2023006038 A MX 2023006038A MX 2023006038 A MX2023006038 A MX 2023006038A
- Authority
- MX
- Mexico
- Prior art keywords
- hpv
- diseases associated
- human papillomavirus
- vaccines against
- pathologies
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10041—Use of virus, viral particle or viral elements as a vector
- C12N2710/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063118222P | 2020-11-25 | 2020-11-25 | |
| PCT/US2021/060605 WO2022115470A1 (en) | 2020-11-25 | 2021-11-23 | Human papilloma virus vaccines and uses of the same for hpv associated diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023006038A true MX2023006038A (es) | 2023-07-11 |
Family
ID=81754898
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023006038A MX2023006038A (es) | 2020-11-25 | 2021-11-23 | Vacunas contra el virus del papiloma humano y usos de estas para enfermedades asociadas a hpv. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240173396A1 (enExample) |
| EP (1) | EP4251278A4 (enExample) |
| JP (1) | JP2023550480A (enExample) |
| KR (1) | KR20230113331A (enExample) |
| CN (1) | CN117203342A (enExample) |
| AU (1) | AU2021385551A1 (enExample) |
| CA (1) | CA3197920A1 (enExample) |
| IL (1) | IL303113A (enExample) |
| MX (1) | MX2023006038A (enExample) |
| WO (1) | WO2022115470A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2026518240A (ja) * | 2023-05-22 | 2026-06-04 | プレシゲン，インコーポレイテッド | 再発性呼吸器乳頭腫症の処置のための新規アデノウイルスワクチン療法 |
| KR20260032470A (ko) * | 2023-05-22 | 2026-03-09 | 프레시전 인코포레이티드 | Hpv 백신 요법의 결과로 생성된 t 세포 수용체 및 이를 이용하여 환자를 치료하는 방법 |
| CN117965634B (zh) * | 2024-04-01 | 2024-07-12 | 北京唯源立康生物科技股份有限公司 | 一种hsv-1病毒载体及其应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPN443995A0 (en) * | 1995-07-27 | 1995-08-17 | Csl Limited | Papillomavirus polyprotein |
| US6225289B1 (en) | 1998-12-10 | 2001-05-01 | Genvec, Inc. | Methods and compositions for preserving adenoviral vectors |
| DK1421200T3 (da) * | 2001-08-23 | 2007-04-10 | Merck & Co Inc | Fluoprescerende multiplex HPV PCR-assays under anvendelse af flere fluoroforer |
| GB0222953D0 (en) * | 2002-10-03 | 2002-11-13 | Glaxo Group Ltd | Novel Compounds |
| EP1732598A4 (en) * | 2003-12-31 | 2009-08-26 | Pharmexa Inc | TRIGGERING CELLULAR IMMUNE RESPONSES TO THE HUMAN PAPILLOVIRUS USING PEPTIDE AND NUCLEIC ACID COMPOSITIONS |
| PL1576967T3 (pl) * | 2004-03-18 | 2008-03-31 | Pasteur Institut | Rekombinowane białko niosące epitopy ludzkiego wirusa brodawczaka wstawione w białko cyklazy adenylanowej lub jego fragment oraz jego zastosowania terapeutyczne |
| EP2288380B1 (en) * | 2008-06-09 | 2020-06-03 | Bharat Biotech International Limited | Vaccine composition useful for hpv and hepatitis b infections and a method for preparing the same |
| US9050287B2 (en) * | 2009-01-23 | 2015-06-09 | The Trustees Of The University Of Pennsylvania | Vaccines for human papilloma virus and methods for using the same |
| KR102373828B1 (ko) * | 2011-10-12 | 2022-03-14 | 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 | 인간 파필로마 바이러스에 대한 백신 및 이것을 사용하는 방법 |
| WO2018060288A1 (en) * | 2016-09-29 | 2018-04-05 | Glaxosmithkline Biologicals S.A. | Compositions and methods of treatment of persistent hpv infection |
| WO2019151760A1 (ko) * | 2018-02-02 | 2019-08-08 | 주식회사 에스엘백시젠 | 신규 다가 hpv 백신 조성물 |
| SG11202008539YA (en) * | 2018-03-06 | 2020-10-29 | Precigen Inc | Human papillomavirus vaccines and uses of the same |
-
2021
- 2021-11-23 CA CA3197920A patent/CA3197920A1/en active Pending
- 2021-11-23 EP EP21899044.8A patent/EP4251278A4/en active Pending
- 2021-11-23 WO PCT/US2021/060605 patent/WO2022115470A1/en not_active Ceased
- 2021-11-23 KR KR1020237020302A patent/KR20230113331A/ko active Pending
- 2021-11-23 US US18/253,624 patent/US20240173396A1/en active Pending
- 2021-11-23 MX MX2023006038A patent/MX2023006038A/es unknown
- 2021-11-23 JP JP2023530809A patent/JP2023550480A/ja active Pending
- 2021-11-23 IL IL303113A patent/IL303113A/en unknown
- 2021-11-23 AU AU2021385551A patent/AU2021385551A1/en active Pending
- 2021-11-23 CN CN202180089584.2A patent/CN117203342A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20240173396A1 (en) | 2024-05-30 |
| CA3197920A1 (en) | 2022-06-02 |
| EP4251278A1 (en) | 2023-10-04 |
| EP4251278A4 (en) | 2025-09-03 |
| CN117203342A (zh) | 2023-12-08 |
| WO2022115470A1 (en) | 2022-06-02 |
| KR20230113331A (ko) | 2023-07-28 |
| AU2021385551A1 (en) | 2023-06-22 |
| IL303113A (en) | 2023-07-01 |
| JP2023550480A (ja) | 2023-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2018014694A (es) | Terapia ultravioleta interna. | |
| MD20150031A2 (ro) | Dispozitiv hiperbaric şi metode de producere a vaccinurilor inactivate şi proteinelor recombinante repliate/solubilizate | |
| CO2022017989A2 (es) | Vacunas para la papilomatosis respiratoria recurrente y métodos para usar estas | |
| WO2021156404A3 (en) | Treatment of hpv-related diseases | |
| PH12016502529B1 (en) | Influenza vaccine nasal vaccination system | |
| MX391627B (es) | Aplicación cuantitativa periorbital de fármacos oftalmológicos. | |
| ECSP22063122A (es) | Vacuna contra hpv | |
| PE20110327A1 (es) | Vacuna contra el virus de papiloma humano | |
| MX2022012447A (es) | Vacuna inactivada contra el virus sars-cov-2. | |
| EP4251278A4 (en) | HUMAN PAPILLOMAVIRUS VACCINES AND THEIR USES FOR HPV-ASSOCIATED DISEASES | |
| MX2022001430A (es) | Formulaciones de vacuna contra chikungu?a. | |
| RU2008142140A (ru) | Противотуберкулезная вакцина | |
| MX2025013955A (es) | Vacunas contra el virus del papiloma humano y usos de las mismas | |
| CL2018002438A1 (es) | Método y composición para el tratamiento del cáncer o una lesión de la piel utilizando una vacuna. | |
| MX2021001288A (es) | Vacunacion con microvesiculas derivadas de celulas tumorales para tratamiento de cancer. | |
| MX2025013954A (es) | Nueva terapia de vacuna de adenovirus para el tratamiento de papilomatosis respiratoria recurrente | |
| AR074485A1 (es) | Vacuna contra lesiones neoplasicas o cancerosas causadas por el virus del papiloma humano (vph), procedimientos, usos y metodos | |
| NZ740627A (en) | Oral suspension for treating eosinophilic esophagitis | |
| CN102949290A (zh) | 一种穴位自身疫苗发生仪 | |
| EA202190589A1 (ru) | Способ комбинированной терапии дисплазии шейки матки, ассоциированной с вирусами папилломы человека | |
| UY31184A1 (es) | Composición vacunal homogénea para el tratamiento del cáncer y su método de obtención | |
| HK40102154A (en) | Human papilloma virus vaccines and uses of the same for hpv associated diseases | |
| AR128249A1 (es) | PROCESO DE PRODUCCIÓN DE UNA PROTEÍNA QUIMÉRICA, LA PROTEÍNA QUIMÉRICA, EL GEN, UNA COMPOSICIÓN INMUNOGÉNICA, Y SUS USOS ASOCIADOS AL SARS-CoV-2 | |
| Shahsavandi | Virus genetic variations and evade from immune system, the present influenza challenges | |
| HK40116587A (en) | Immunogenic constructs and vaccines for use in the prophylactic and therapeutic treatment of diseases caused by sars-cov-2 |